Evidence map›Paper›PMID 27979026›Full record

ArticleAnnals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology2016

IL-17RB

Lin Li, Nicholas W Lukacs, Matthew A Schaller, Bryan Petersen, Alan P Baptist

Abstract read
In one paragraph

Article in Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Lin LiDivision of Allergy and Immunology, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan.
Nicholas W LukacsDepartment of Pathology, University of Michigan Medical School, Ann Arbor, Michigan.
Matthew A SchallerDepartment of Pathology, University of Michigan Medical School, Ann Arbor, Michigan.
Bryan PetersenDepartment of Pathology, University of Michigan Medical School, Ann Arbor, Michigan.
Alan P BaptistDivision of Allergy and Immunology, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan. Electronic address: abaptist@med.umich.edu.
University of Michigan–Ann Arbor · US

Funding

The Role of C-C Chemokines in Eosinophil Airway InflammationR01AI036302 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LUKACS, NICHOLAS W · 2001 to 2018
$5.6M
THE ROLE OF SCF IN EOSINOPHIL LUNG INFLAMATIONR01HL059178 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LUKACS, NICHOLAS W · 1999 to 2013
$3.3M
NHLBI NIH HHS R01 HL059178NIAID NIH HHS R01 AI036302
6 · The paper itself

Abstract

backgroundInterleukin (IL)-25 (IL-17E) is a proinflammatory cytokine that plays an important role in the T-helper type 2 cell pathway. The effects of IL-25 are mediated by its specific receptor, IL-17RB. Previous studies have defined an IL-17RB

objectiveTo investigate the relation of IL-17RB

methodsPeripheral blood from subjects with asthma and healthy controls was collected and analyzed by flow cytometry. Granulocytes were gated for IL-17RB

resultsPercentages of IL-17RB

conclusionIL-17RB

Indexed as

AdultAirway ObstructionAsthmaBiomarkersCase-Control StudiesEosinophilsFemaleFluorescent Antibody TechniqueForced Expiratory VolumeGranulocytesHumansImmunophenotypingLeukocyte CountMaleMiddle AgedPhenotypeBiomarkersIL17RB protein, humanReceptors, InterleukinReceptors, Interleukin-17

Identifiers

PMID27979026
PMCPMC5172383
OpenAlexW2561712586

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.